Skip to main content
Top

Indian Journal of Gastroenterology

Issue 5/2009

Content (9 Articles)

Editorial

In the search of a cause of Crohn’s disease

Govind K. Makharia, Urvashi B. Singh

Original Article

Absence of Mycobacterium avium ss paratuberculosis-specific IS900 sequence in intestinal biopsy tissues of Indian patients with Crohn’s disease

Mitnala Sasikala, D. Nageshwar Reddy, Nitesh Pratap, Sanjeev Kumar Sharma, P. Reddy Balkumar, Anuradha Sekaran, Rupa Banerjee, D. Bhaskara Reddy

Short Report

Role of intravenous naloxone in severe pruritus of acute cholestasis

Gunjan G. Joshi, B. S. Thakur, Shohini Sircar, Arvind Namdeo, Ajay K. Jain

Short Report

Role of ultrathin transnasal esophagogastroduodenoscopy: experience with 50 patients

Avnish Kumar Seth, Pankaj Puri, Alok Chandra

Case Report

‘Pancreatitis, polyarthritis, panniculitis syndrome’ (PPP syndrome) plus prolonged pyrexia-a rare presentation of chronic pancreatitis

Tony Jose, I. K. Biju, Anish Kumar, P. C. Anver, Rojan Kuruvila, Shalini Kuruvila, M. Lilly

Letters

Celiac disease, still an uncommon problem in Tamilians?

R. Ganesh, N. Suresh, M. Sathiyasekaran

Letters

Use of linseed oil in preventing peri-ileostomy skin excoriation

Sunil Saxena, Seema Suryawanshi, Uday Somashekar, Dhananjaya Sharma

Gastroenterology Research

Gastroenterology elsewhere

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine